Skip to content

Propel Bio Management, LLC

Follow

13F filer, CIK 1969764, LOS ANGELES, CA

Propel Bio Management, LLC reported $188,617,909 across 30 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-13. Its ten largest share positions make up 68.27% of the portfolio.

Accepted , ingested 13F-HR 0001829126-26-012373

Period
2026-09-30
Reported value
$189M
Holdings
30
Top 10 weight
68.27%
New
5
Sold out
4

Largest buys vs the previous quarter

SecurityShares changeApprox. value
COLLnew+410,175$8.95M
MAZEadded+148,200$4.03M
CABAnew+2,049,471$3.93M
PROKnew+2,009,733$3.34M
CRVSadded+193,930$2.23M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
AQSTreduced-1,163,674-$35.9M
CORTreduced-61,225-$7.05M
DCTHreduced-266,796-$4.26M
ZVRAexited-253,544-$3.64M
EYPTexited-191,745-$2.74M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001829126-26-012373, largest first. % of portfolio is the value over $188,617,909, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
PAGPPLAINS GP HLDGS L PQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,272,360 shares; 2025Q1: 1,272,360 shares; 2025Q2: 1,272,360 shares; 2025Q3: 1,272,360 shares; 2025Q4: 1,272,360 shares; 2026Q1: 1,272,360 shares; 2026Q2: 1,272,360 shares; 2026Q3: 1,272,360 shares 1,272,360$33M17.47%0Timeline
ACHVACHIEVE LIFE SCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,453,092 shares; 2025Q1: 2,453,092 shares; 2025Q2: 6,153,091 shares; 2025Q3: 3,786,425 shares; 2025Q4: 3,786,425 shares; 2026Q1: 3,786,425 shares; 2026Q2: 4,034,018 shares; 2026Q3: 3,864,148 shares 3,864,148$31.3M16.57%-169,870Timeline
DCTHDELCATH SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 17,000 shares; 2025Q1: 177,600 shares; 2025Q2: 226,052 shares; 2025Q3: 438,509 shares; 2025Q4: 438,509 shares; 2026Q1: 979,698 shares; 2026Q2: 871,460 shares; 2026Q3: 604,664 shares 604,664$9.66M5.12%-266,796Timeline
COLLCOLLEGIUM PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 410,175 shares 410,175$8.95M4.75%newTimeline
CORTCORCEPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 147,828 shares; 2026Q2: 136,499 shares; 2026Q3: 75,274 shares 75,274$8.67M4.6%-61,225Timeline
AQSTAQUESTIVE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 710,988 shares; 2026Q2: 1,442,397 shares; 2026Q3: 278,723 shares 278,723$8.61M4.56%-1,163,674Timeline
MISTMILESTONE PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,451,557 shares; 2025Q2: 1,791,557 shares; 2025Q3: 5,124,890 shares; 2025Q4: 4,118,321 shares; 2026Q1: 4,118,321 shares; 2026Q2: 7,429,590 shares; 2026Q3: 9,449,727 shares 9,449,727$8.18M4.34%+2,020,1372026-11-19, 13G/A: 12,615,010 shares, 10.1% of the class, 13G/A filed 2026-11-20 Timeline
PHATPHATHOM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 989,927 shares; 2025Q1: 1,134,927 shares; 2025Q2: 922,927 shares; 2025Q3: 552,927 shares; 2025Q4: 740,918 shares; 2026Q1: 841,272 shares; 2026Q2: 1,050,358 shares; 2026Q3: 1,105,913 shares 1,105,913$8.07M4.28%+55,555Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 25,209 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 510,000 shares; 2025Q4: 861,778 shares; 2026Q1: 742,049 shares; 2026Q2: 573,086 shares; 2026Q3: 549,186 shares 549,186$6.83M3.62%-23,900Timeline
OBIOORCHESTRA BIOMED HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 896,701 shares; 2026Q2: 896,701 shares; 2026Q3: 896,701 shares 896,701$5.58M2.96%0Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 43,798 shares; 2026Q2: 43,798 shares; 2026Q3: 191,998 shares 191,998$5.22M2.77%+148,200Timeline
ABEOABEONA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 624,022 shares; 2025Q1: 624,022 shares; 2025Q2: 974,022 shares; 2025Q3: 974,022 shares; 2025Q4: 830,780 shares; 2026Q1: 1,329,899 shares; 2026Q2: 983,070 shares; 2026Q3: 956,007 shares 956,007$5.02M2.66%-27,063Timeline
ARTVARTIVA BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 146,369 shares; 2026Q2: 696,436 shares; 2026Q3: 696,436 shares 696,436$4.96M2.63%0Timeline
KYTXKYVERNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 666,666 shares; 2026Q1: 644,421 shares; 2026Q2: 883,198 shares; 2026Q3: 700,595 shares 700,595$4.76M2.53%-182,603Timeline
IVAINVENTIVA SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,000,000 shares; 2026Q1: 724,678 shares; 2026Q2: 1,281,212 shares; 2026Q3: 1,133,954 shares 1,133,954$4.18M2.22%-147,258Timeline
CABACABALETTA BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,049,471 shares 2,049,471$3.93M2.09%newTimeline
SABSSAB BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 652,881 shares; 2026Q1: 1,012,790 shares; 2026Q2: 1,076,578 shares; 2026Q3: 1,187,422 shares 1,187,422$3.76M2%+110,844Timeline
PROKPROKIDNEY CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,009,733 shares 2,009,733$3.34M1.77%newTimeline
CRVSCORVUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 85,791 shares; 2026Q2: 70,380 shares; 2026Q3: 264,310 shares 264,310$3.04M1.61%+193,930Timeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,115,000 shares; 2026Q2: 2,582,388 shares; 2026Q3: 2,224,189 shares 2,224,189$3M1.59%-358,199Timeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 382,375 shares; 2026Q2: 357,966 shares; 2026Q3: 357,966 shares 357,966$2.75M1.46%0Timeline
SCYXSCYNEXIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 543,478 shares; 2026Q3: 541,474 shares 541,474$2.67M1.42%-2,004Timeline
FDMT4D MOLECULAR THERAPEUTICS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 380,420 shares; 2026Q2: 252,654 shares; 2026Q3: 179,154 shares 179,154$2.56M1.36%-73,500Timeline
OVIDOVID THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 921,457 shares; 2026Q2: 1,115,538 shares; 2026Q3: 1,018,721 shares 1,018,721$2.54M1.34%-96,817Timeline
IMUXIMMUNIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 325,022 shares; 2026Q3: 236,734 shares 236,734$2.2M1.17%-88,288Timeline
UPBUPSTREAM BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 341,779 shares; 2026Q2: 350,389 shares; 2026Q3: 335,389 shares 335,389$1.77M0.94%-15,000Timeline
IRDOPUS GENETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 270,036 shares 270,036$1.31M0.69%newTimeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 155,000 shares; 2025Q4: 154,300 shares; 2026Q1: 131,364 shares; 2026Q2: 103,695 shares; 2026Q3: 37,539 shares 37,539$1.22M0.65%-66,156Timeline
SGPSPYGLASS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 41,418 shares 41,418$1.08M0.57%newTimeline
LONALEONABIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 149,279 shares; 2025Q4: 149,279 shares; 2026Q1: 149,279 shares; 2026Q2: 149,279 shares; 2026Q3: 149,279 shares 149,279$533K0.28%0Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ZVRAZEVRA THERAPEUTICS INC253,544$3.64Mshares
EYPTEYEPOINT INC191,745$2.74Mshares
SLNSILENCE THERAPEUTICS PLC191,733$2.11Mshares
SGMTSAGIMET BIOSCIENCES INC125,878$973Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001829126-26-012373 base2026-11-13